CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph […] Read More… from CATTI opens a cell and gene therapy training centre of excellence at the University of Guelph
Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies […] Read More… from Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies
OmniaBio expands manufacturing footprint with second Hamilton location […] Read More… from OmniaBio expands manufacturing footprint with second Hamilton location
Invest Ontario Supports New Biomanufacturing Facility in Hamilton. […] Read More… from Invest Ontario Supports New Biomanufacturing Facility in Hamilton.
Funding from Ontario Government for OmniaBio. […] Read More… from Funding from Ontario Government for OmniaBio.
OmniaBio Inc. announces private investor. […] Read More… from OmniaBio Inc. announces private investor.
NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada. […] Read More… from NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada.
OmniaBio celebrates the beginning of construction. […] Read More… from OmniaBio celebrates the beginning of construction.
Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio. […] Read More… from Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio.
Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology. […] Read More… from Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology.